Daniel E. Ryweck
CIK: 0001652799
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SILO
Silo Pharma, Inc.
Officer
Discretionary Trading P&L
Holdings
About Ryweck Daniel E.
Ryweck Daniel E. (SEC CIK 0001652799) files insider reports with the SEC as Chief Financial Officer of Silo Pharma, Inc. (SILO).
Signal8 holds 1 ownership filing by Ryweck Daniel E., a Form 4, filed on May 27, 2025. Those filings report 1 transaction, the latest on May 23, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Ryweck Daniel E.'s filings is in SARASOTA, FL.
Recent filings by Ryweck Daniel E.
- May 23, 2025: Grant or award of SILO derivative securities (Form 4, code A).
Other insiders filing for Silo Pharma, Inc. (SILO)
- Weisblum Eric, CEO and President
- Linsley Wayne, Director
- Munoz Kevin, Director
- Pavell Jeff, Director